Cargando…

Early Diagnosis of Alzheimer’s Disease: Moving Toward a Blood-Based Biomarkers Era

Detalles Bibliográficos
Autores principales:	Tao, Qing-Qing, Lin, Rong-Rong, Wu, Zhi-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10001034/ https://www.ncbi.nlm.nih.gov/pubmed/36911809 http://dx.doi.org/10.2147/CIA.S394821

Ejemplares similares

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Optimal Combinations of AT(N) Biomarkers to Determine Longitudinal Cognition in the Alzheimer's Disease
por: Lin, Rong-Rong, et al.
Publicado: (2021)

Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment
por: Tao, Qing-Qing, et al.
Publicado: (2017)

Should CSF Biomarkers Support a Routine Analysis for Early Diagnosis of Alzheimer's Disease?
por: Parnetti, Lucilla, et al.
Publicado: (2010)

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
por: Jellinger, Kurt A, et al.
Publicado: (2008)

Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer’s Disease
por: Fortea, Juan, et al.
Publicado: (2023)

Serum sirtuin1: a potential blood biomarker for early diagnosis of Alzheimer’s disease
por: Wang, Jia, et al.
Publicado: (2023)

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum
por: Chen, Yi-He, et al.
Publicado: (2022)

A Review of Fluid Biomarkers for Alzheimer’s Disease: Moving from CSF to Blood
por: Blennow, Kaj
Publicado: (2017)

European Endodontic Journal – Moving Forward to a New Era
por: Çapar, İsmail Davut, et al.
Publicado: (2023)

Moving Toward the Future: Online Only
por: Wang, Jeffrey C., et al.
Publicado: (2019)

Consolidating the Past, Moving Towards the Future
por: Costa, Angelo Brandelli, et al.
Publicado: (2021)

The moving target of psychiatric diagnosis
por: Alda, Martin
Publicado: (2021)

Biomarkers for Alzheimer’s Disease Early Diagnosis
por: Ausó, Eva, et al.
Publicado: (2020)

Transcriptional profiling of apoptosis: Cell death classification moves toward the systems era
por: Yao, Zhi, et al.
Publicado: (2012)

Organized medicine in the progressive era. The move toward monopoly
Publicado: (1979)

Moving towards personalized medicine in rheumatoid arthritis
por: de Jong, Tamarah D, et al.
Publicado: (2014)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

Behavioural biomarkers of typical Rett syndrome: moving towards early identification
por: Einspieler, Christa, et al.
Publicado: (2016)

Ocular Vascular Changes: Choroidal Thickness as an Early Biomarker for Alzheimer’s Disease?
por: Villa, Chiara
Publicado: (2021)

Escaping from, moving towards, following a path, squeezing through: lots of opportunities for moving cells
por: Chiarugi, Paola
Publicado: (2010)

Moving Toward the Optimal Test for the Assessment of Myocardial Ischemia
por: Nagel, Eike
Publicado: (2016)

Moving toward More Frequent On-Line Only Journal
por: Choe, Yeon Hyeon
Publicado: (2019)

Healthcare for Older Adults, Where Are We Moving towards?
por: Tarazona-Santabalbina, Francisco José, et al.
Publicado: (2021)

Moving Towards a Common Alarm Service for the LHC Era
por: Calderini, F, et al.
Publicado: (2003)

Moving towards online rheumatology education in the era of COVID-19
por: Ahmed, Sakir, et al.
Publicado: (2020)

Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers
por: Gabbia, Daniela, et al.
Publicado: (2023)

Blood biomarkers for memory: toward early detection of risk for Alzheimer disease, pharmacogenomics, and repurposed drugs
por: Niculescu, A. B., et al.
Publicado: (2019)

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
por: Arenaza-Urquijo, Eider M., et al.
Publicado: (2015)

Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023)

Novel Hominid-Specific IAPP Isoforms: Potential Biomarkers of Early Alzheimer’s Disease and Inhibitors of Amyloid Formation
por: Liu, Qing-Rong, et al.
Publicado: (2023)

Are we moving towards a new definition of essential medicines?
por: Manikandan, S
Publicado: (2015)

Moving towards better cause of death registration in Africa and Asia
por: Boerma, Ties
Publicado: (2014)

Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s Disease
por: Villa, Chiara, et al.
Publicado: (2022)

Advances in retina imaging as potential biomarkers for early diagnosis of Alzheimer’s disease
por: Zhang, Ying, et al.
Publicado: (2021)

Emerging biomarkers for early diagnosis of pancreatic cancer
por: eBioMedicine
Publicado: (2022)

Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through RNA sequencing analysis
por: Shigemizu, Daichi, et al.
Publicado: (2020)

Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through immune landscape analysis
por: Shigemizu, Daichi, et al.
Publicado: (2022)

Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
por: Seto, Mabel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66fs0nj9bbck3vqdf6qbli95kf